A B S T R A C T An 18-yr-old black woman in good general health was found to lack serum hemolytic complement activity.'The sixth component of complement (C6) was undetectable by functional assay of serum or plasma and by immunoprecipitin analysis of serum. Functional titers of all other complement components were normal. The absence of C6 in the patient's serum could not be accounted for by a circulating C6 inhibitor, and addition of functionally pure C6 to the patient's serum restored hemolytic activity to normal. Both parents of the proband and five of six available siblings had approximately half the normal levels of functional C6. The other sibling had a normal C6 level. These data suggest that both parents and five siblings are heterozygous for C6 deficiency, while the proband is homozygous and one sibling is normal. Thus, C6 deficiency appears to follow classic mendelian inheritance, with all three possible genotypes recognizable within the family.
Functional properties of the proband's C6-deficient serum included total absence of bactericidal activity against Salmonella typhi 0 901 and Hemophilus influenzae, type b, and inability to mediate lysis of red blood cells from patients with paroxysmal nocturnal hemoglobinuria in either the acidified serum or "sugar water" tests. The proband's serum did, however, exhibit a normal INTRODUCTION Recent studies of complement deficiency states in man and experimental animals have contributed greatly to our understanding of the role of the complement (C)1 system in host defense, inflammation, and tissue injury (1, 2) . Human families have been identified with genetically controlled deficiency of the second C component (C2) (3) (4) (5) (6) or of the Cir subcomponent of Cl (7, 8) , two proteins which act early in the "classical" sequence of C activation (1) . An apparently high proportion of individuals with these hereditary C deficiencies have been reported to exhibit rheumatic disorders, renal disease, and autoimmune phenomena (7) (8) (9) (10) (11) . Patients with C3 deficiency and abnormalities of C5 function have also been described, and both of these disorders have been associated with increased susceptibility to pyogenic infection (12) (13) (14) (15) .
It is the purpose of this report to describe a new hereditary deficiency of one of the late-acting components in the C sequence, C6, in a human kindred and to examine the functional properties of C6-deficient human serum. This defect is as yet unassociated with definite clinical illness. CASE SUMMARY D. B., an 18-yr-old married black female, was admitted to the University of Rochester Medical Center in August 1971 with a 1-day history of fever, chills, polyarthralgia, and painful fingertip lesions. The patient denied vaginal discharge but did describe occasional left lower abdominal pain in the preceding week. Past health had been excellent except for admission to another hospital 13 mo earlier for gonococcal arthritis which had responded to penicillin therapy.
Examination revealed rectal temperature 101.40F and extremely tender, raised, erythematous 5-mm skin lesions on the tips of both index fingers, consistent with hemorrhagic infarcts. There was tenderness and slight swelling of several small joints of both hands and the right foot, as well as tenosynovitis affecting several tendon groups in the left leg. The abdomen was negative. Pelvic examination revealed white, mucoid vaginal discharge, tenderness of the uterus and adnexa, but no masses.
A positive culture for Neisseria gonorrheae was obtained from the uterine cervix. Three blood cultures were negative and a rectal culture showed normal flora. Other laboratory data included: hematocrit 34%; white blood cells 7,400 with a slight "left shift"; normal platelets on smear; negative urine analysis; negative Venereal Disease Research Laboratory (VDRL) test for syphilis; normal blood chemistries including bilirubin, alkaline phosphatase, lactic dehydrogenase, glutamic-oxaloacetic transaminase, urea nitrogen, creatinine, uric acid, total proteins, and albumin. A screening test revealed de- ficiency of red blood cell (RBC) glucose-6-phosphate dehydrogenase. Because the original differential diagnosis included lupus erythematosus (LE), tests for antinuclear antibody, LE cells, and serum complement were obtained. The former two tests were negative but the hemolytic complement (CH5o) titer was < 5 U/ml (normal range 80-160). This was confirmed on several additional samples of fresh serum, including one obtained.
after the patient had fully recovered.
A diagnosis of gonorrhea with probable gonococcemia was made. Treatment with large doses of penicillin plus probenecid was followed by rapid clearing of fever and other symptoms, and the patient has remained well during subsequent observation as an outpatient.
When it became clear that the extremely low CH5o titer represented a specific deficiency of C6 (see below), the patient was recalled for a more directed clinical history and examination and for clotting studies (16) . Hemolytic C (CH50) titers were determined as previously reported (20) . Individual, functionally pure guinea pig and human complement components (C3-9) were obtained from the Cordis Corp., Miami, Fla. Sources of materials and buffers and methods for the preparation of cellular intermediates in the complement system have been described in detail (21, 22) . Functional assays of each of the nine complement components were performed as previously described (23) .
Assays of C6 were performed by two methods. In the first method, involving stepwise buildup of components on antibody sensitized erythrocytes (EA), human components were used throughout. To 0.25 ml of the test dilution in dextrose-Veronal-buffered saline (DVBS) (22) was addedO.25 ml of a reagent containing C3 (50 U/ml), C5 (50 U/ml), and C7 (50 U/ml). To this mixture were added 0.25 ml C2 (100 U/ml) and 0.25 ml EAC14 (1 X 108 cells/ml, Tmax= 2 min). After incubating the reaction mixture at 30'C for 30 min, 0.25 ml of a mixture containing C8 (500 U/ml) and C9 (500 U/ml) were added and the reaction incubated for a further 60 min at 37'C. Then 2.5 ml ice-cold EDTAbuffer (isotonic Veronal buffer containing 0.01 M EDTA) were added and the degree of hemolysis determined. Controls included the various reagents in the absence of a serum C6 source, a functionally pure C6 source, and water-lysed cells to determine the absorbance at 100%o hemolysis. Data were plotted according to the Poisson distribution and the one-hit theory of complement action (24) . These C6 titrations were performed on sera from all members of the family and 14 normal controls with the same set of reagents to minimize error.
A second method was developed for C6 titration utilizing serum from rabbits genetically deficient in C6. A volume of 0.25 ml of sensitized sheep RBC, containing 1.5 X 108 cells/ml in DVBS, was mixed with 0.25 ml C6-deficient rabbit serum diluted 1/20 in DVBS and the mixture incubated at 37'C for 30 min. To the mixture was added 0.25 ml of a dilution of the C6 source in the same buffer and the mixture incubated for an additional 90 min at 37°C. A volume of 2.5 ml ice-cold EDTA-buffer was added to stop the reaction and the degree of hemolysis measured. That dilution of serum required to form an average of one C6 site per cell (24) in this system was defined as the C6 titer.
Immune adherence reactions were performed in microtiter plates as follows. Serial dilutions of the patient's serum or control serum (25 ,ul (26), with the following exceptions. The bacteria were taken from an 18-h broth culture in beef heart infusion; incubation of sensitized bacteria with human sera was at 370C for 60 min. Specific rabbit antiserum to S. typhi 0 901 was kindly provided by Dr. Gabriel Michael, University of Cincinnati School of Medicine, Cincinnati, Ohio. In preliminary studies employing a 1/5 dilution of agammaglobulinemic human serum as the C source, it was found that maximum bacterial killing could be achieved over a broad range of dilutions of the rabbit antiserum from 1/100 to 1/12,800. A 1/6,400 dilution was chosen for the actual assays. Five normal sera and C6-deficient serum were tested concurrently as the C source, with and without the addition of 1/6,400 rabbit antiserum. For bactericidal assays against H. influenzae 0.2 ml from an overnight broth culture was added to 5 ml fresh Levinthal's broth and incubated at 37'C for 4-h. This subculture was then diluted 1/1,000 in phosphate-buffered saline (PBS), pH 7.4, containing 3 X 10' M Ca++ and 2 X 10' M Mg++. The reaction mixtures, in polystyrene tubes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.), consisted of 0.025 ml of the diluted bacteria, 0.05 ml PBS, 0.05 ml of complement source (normal or patient's serum in twofold dilutions from undiluted to 1/32), and 0.025 ml immune rabbit serum, diluted 1/256 in PBS, to insure the presence of optimal antibody. Immediately after mixing (zero time) and after 60 min at 37°C the contents of each tube were streaked onto chocolate agar plates with calibrated loops. The plates were incubated at 37°C for 24 h in 5% C02, after which colonies were counted. Standard controls were run in each assay.
Chemotactic assays. Assays with peripheral white blood cells of normal human donors were performed in a modified Sykes-Moore chamber with a 3-Am Millipore filter, as described elsewhere (27) . Results are expressed as a ratio, the chemotactic index, which is explained in reference 27
The formula used to calculate the chemotactic index ii1 the present study is (28): number of cells (attractant side) 500 number of cells (starting side) X Escherichia coli 0 111: B4. E. coli endotoxin (Difco Laboratories, Detroit, Mich.) or heat-aggregated (65°C, 20 min) human IgG served as activating agents. 4 vol of endotoxin (1 ,ug/ml) or aggregated IgG (1 mg/ml) were mixed with 1 vol of undiluted human serum serving as C source and allowed to stand for 20 min at room temperature before injection into the lower section of the chamber and the start of the 3-h incubation at 37°C. In all experiments normal and C6-deficient sera were tested concurrently, using the white blood cells of a given normal donor. To obtain the dose-response curves shown in Fig. 3 Group 0 adult RBC (2.5%) were incubated in 1/10 dilutions of fresh serum and isolated anti-I cold agglutinins at 200C for 90 min. After a 10-min incubation at 37'C the RBC were washed 3 times in 37'C saline, resuspended to 2.5% and tested in antiglobulin (Coombs) reactions with anti-C3 and anti-C4 as previously described (17) . The cold agglutinins used had previously been purified by adsorption to human RBC at 4VC and elution at 37'C.
Paroxysmal noctural hemoglobinuria (PNH). Lysis of PNH red cells employed a standard acid hemolysis test (29) and a modification of the sugar water test (30) as follows. Washed RBC were suspended to 50% in test serum. To 0.1 ml of this cell suspension was added 0.9 ml of the sucrose solution, and the mixture was incubated at 37'C 30 min. After centrifugation the degree of lysis in supernates (diluted 1/20) was determined by OD at 413 nm.
Cryoglobulins. Cryoglobulins were measured and isolated as previously described (31) (Fig. 1) . Both antisera consistently produced single precipitin lines with normal sera. Study of serial dilutions of the normal sera suggested that 10-20% of the normal concentration of C6 protein could have been detected by this means. It may also be noted in Fig. 1 Family studies. Shown in Fig. 2 is the family pedigree, with age, whole hemolytic C (CHso) titer and specific C6 titer (method I) listed for each family member studied. Using the same reagents, C6 assays were carried out on a panel of 14 normal controls,2 from which the mean ±SE are given in the box insert (Fig. 2) . On repeated determinations both parents and five of the six available siblings had approximately half the normal level of C6. One sibling (II-5) had C6 values clearly in the normal range.
The sera of all family members, other than the proband, exhibited a clearly visible precipitin line in two- dimensional gel diffusion against anti-C6. Quantitative radial immunodiffusion with antirabbit C6 appeared capable of distinguishing normal sera from sera which had shown half-normal C6 functional levels. This antiserum was relatively weak, however, and the ring diameters were small, making readings difficult. Also noteworthy in Fig. 2 is the finding that halfnormal levels of C6 were sufficient to allow normal whole C (CH5o) titers. This indicates that the heterozygous C6-deficient state apparently cannot be detected by whole hemolytic C titration, presumably because even half-normal C6 levels are not limiting in such assays.
18 other normal individuals have had C6 measurements on other occasions. All but one had C6 titers in the normal range. One white female, however, has consistently shown C6 values slightly lower than the proposed heterozygotes in Fig. 2 . This subject, therefore, may well be heterozygous for C6 deficiency, although family studies have not yet been done.
Functional properties of C6-deficient human serum. D. B. serum displayed a total lack of bactericidal activity against S. typhi 0 901, in the presence or absence of optimal amounts of specific rabbit antibody to this organism (Table IV) Table VI . This screening assay employs human serum in a final dilution of 1/5. In an attempt to make the assay more sensitive to possible differences between normal and C6-deficient serum, increasing dilutions of normal and C6-deficient sera were tested as C sources in the presence of aggregated IgG or endotoxin. As That the absence-of C6 represents a synthetic defect is suggested by (a) the selective nature of the C defect; (b) the genetic analysis (Fig. 2) ; (c) our inability to attribute the C6 defect to a serum inhibitor or to bindinig by the small quantity of cryoglobulins present in the proband's serum. The absence of C6 in her plasma rules against consumption of C6 during blood clotting (34) (35) (36) .
The C6 deficiency appears to follow classic mendelian inheritance, with all three possible genotypes recognizable within this family (Fig. 2) . A similar mode of inheritance has been observed in human C2 deficiency (3-6, 9) and C3 deficiency (12, 14) . The heterozygous state in the present kindred can be recognized by specific C6 titration, with heterozygotes having about half-normal functional levels of C6 (Fig. 2) . In this respect the inheritance of C6 deficiency in this family resembles that noted in C6-deficient rabbits (18, 37) . The unexpected finding of an apparently healthy individual in the control population with a half-normal level of C6 raises the possibility that C6 deficiency in man may be less rare than expected.
C6-deficient rabbits have been the subject of detailed experimental analysis and it was, therefore, of great interest to compare the functional properties of the C6-deficient serum of the human proband. A detailed examination of hemostatic function is presented in the companion paper (16) . The complete lack of bactericidal or cytolytic activity in the proband's serum is consistent with total absence of C6 activity. Similhr findings have been reported in C6-deficient rabbits (26) . The contrasting performances of C6-deficient and C2-deficient human sera in concurrent bactericidal assays against S. typhi (Table IV) and H. influenzae (see above) provide further evidence for a dominant role of the alternate pathway in this function (38) (39) (40) .
C6-deficient rabbits apparently are not unusually susceptible to infections (1, 18) but are reported to be abnormally sensitive to endotoxin in vivo (41) . Our homozygous C6-deficient patient has had no special problem with infections, including those due to gram negative bacteria, despite the total lack of serum bactericidal capacity. The latter mechanism may be less important in vivo than other mechanisms, e.g., intracellular killing. Possibly the patient has not had a maximal bacterial challenge, although she probably has had two episodes of gonococcemia without unusual complications.
C6-deficient rabbit serum originally had been reported to show deficient generation of chemotactic activity in vitro in the presence of immune complexes (42) . This defect seemed attributable to an inability to form the C567 chemotactic complex (43) , the only C-derived chemotactic factor known at that time. Subsequently, two other laboratories found that C6-deficient rabbit serum and normal rabbit serum produced equivalent amounts of chemotactic activity in response to endotoxin (44) or immune complexes (44, 45) . Technical differences, particularly in pore size of filters, may have contributed to this discrepancy. In the present investigation, using filters similar to the later studies (44, 45) , C6-deficient human serum supported normal generation of chemotactic activity in the presence of endotoxin or aggregated human IgG (Table VI and Fig. 3 ). The findings in Table VI were confirmed by Dr. John Gallin, National Institute of Allergy and Infectious Diseases, Bethesda, Md., using a different assay method (46) . The generation of normal chemotactic activity in C6-deficient human serum appears to be attributable to adequate formation of C5a (45, 47, 48) . A requirement for the C567 complex was not evident under the conditions of our assay.
Also reported here is the observation that serum from this C6-deficient patient does not support lysis of PNH RBC at low ionic strength (sugar water test) or in acidified serum (Table V) . This emphasizes the complementdependent nature of PNH hemolysis. In contrast, C2-deficient human serum, shown to have an intact alternate pathway function but to totally lack an operative classical pathway, did support lysis in acidified serum but not in the sugar water test (Table V) . These data support the conclusion that the lysis of PNH RBC proceeds via the alternate pathway in the acidified serum test (49) (50) (51) , and via the classical pathway in the sugar water test. On the other hand, Logue, Rosse, and Adams (51) observed significant but subnormal lysis of PNH RBC incubated at low ionic strength with hereditary angioedema serum which had been incubated at 370C immediately before testing in order to deplete residual C4. While some technical differences were involved, it is also -possible that the hereditary angioedema serum was not as devoid of classical pathway activity as our C2-deficient serum.
As a final point, reference has already been made to the recent reports of rheumatic disorders and autoimmune phenomena in patients with hereditary C deficiences. The C6-deficient proband, patient D. B., is in good general health but the occurrence of mild Raynaud's phenomenon and "mixed type" cryoglobulins, however small in quantity, may be viewed with suspicion in an 18-yr-old female. Long-term follow-up will therefore be of great clinical interest.
